| Literature DB >> 34277236 |
Harpreet Gosal1,2, Harsimran Kaur3, Hyginus Chakwop Ngassa4,5, Khaled A Elmenawi6,7, Vishwanath Anil1, Lubna Mohammed1.
Abstract
Non-alcoholic fatty liver disease (NAFLD) is the accumulation of intrahepatic fat occurring in the absence of alcohol abuse. The fatty changes in the liver are often the beginning of sequelae of complications, potentially causing steatohepatitis, liver cirrhosis, and hepatocellular carcinoma. The Mediterranean diet is not only a way of eating but is considered a lifestyle and primarily consists of a plant-based diet, with olive oil as the primary lipid. In this study, we reviewed the effectiveness of the Mediterranean diet on NAFLD and its efficacy in disease management. This systematic review follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocol (PRISMA-P) 2009 guidelines. The PubMed database was used to gather articles, using the following terms individually and in combination, "Mediterranean diet," "non-alcoholic fatty liver disease," "insulin resistance," "metabolic syndrome," "omega-3-fatty acids." A quality appraisal was completed to include 14 articles in this systematic review. The studies discuss the correlation between the Mediterranean diet and its role in preventing and treating NAFLD. Olive oil is the major monounsaturated fatty acid, whereas nuts, seeds, and fish consist largely of polyunsaturated fatty acids, both of which are essential components of the Mediterranean diet. The plant-based diet, having sufficient amounts of vegetables, legumes, and fruits, provides its anti-oxidant and anti-inflammatory effects, playing a fundamental role in preventing oxidative stress damage. Olive oil polyphenols increase apoptosis and cell cycle arrest. They also decrease proliferation and angiogenesis, all of which prevent neoplasia. Adapting the Mediterranean lifestyle has shown promising effects in NAFLD, reducing overall mortality and morbidity.Entities:
Keywords: mediterranean diet; nash and steatosis; nonalcoholic fatty liver disease (nafld); olive oil; plant-based diet
Year: 2021 PMID: 34277236 PMCID: PMC8275052 DOI: 10.7759/cureus.15618
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Search strategy with MeSH terms
MeSH: medical subject headings; NAFLD: non-alcoholic fatty liver disease
| Keyword | Database | Before inclusion/exclusion | After inclusion/exclusion |
| Insulin resistance [MeSH] AND fatty steatosis [MeSH] | PubMed | 1056 | 136 |
| Mediterranean diet [MeSH] | PubMed | 341 | 79 |
| NAFLD [MeSH] AND omega-3-fatty acids [MeSH] | PubMed | 101 | 34 |
| NAFLD [MeSH] AND Mediterranean diet [MeSH] | PubMed | 4 | 4 |
| Insulin resistance [MeSH] AND Mediterranean diet [MeSH] | PubMed | 6 | 0 |
Search strategy with keywords
| Keyword | Database | Number of results |
| Non-alcoholic fatty liver disease | PubMed | 20,220 |
| Mediterranean diet | PubMed | 7903 |
| Insulin resistance and Mediterranean diet | PubMed | 622 |
| Metabolic syndrome and Mediterranean diet | PubMed | 551 |
| NAFLD and omega-3-fatty acids | PubMed | 307 |
| NAFLD and Mediterranean diet | PubMed | 154 |
Figure 1PRISMA flow diagram
PRISMA: Preferred Reporting Items for Systematic Review and Meta-Analysis
Figure 2Mediterranean diet pyramid
Observational and experimental studies illustrating the relationship between NAFLD and the Mediterranean diet
NAFLD: non-alcoholic fatty liver disease
| References | Study type | Study characteristics | Method | Outcome |
| Biolato et al., 2019 [ | Crossover | 90 Caucasian patients, 90% male, median age 43 years, body mass index 309 with NAFLD (confirmed by biopsy) | Participants underwent 16 weeks of the Mediterranean diet, 16 weeks of a free wash-out, and 16 weeks of the low-fat diet | Mediterranean diet can improve intestinal permeability in patients with NAFLD, hence is effective in treating visceral obesity and elevated serum transaminase |
| Mirizzi et al., 2019 [ | Cross-sectional study | 136 participants | Diagnosis of NAFLD was determined using vibration-controlled elastography on a FibroScan and categorized as either NAFLD absent (<215 dB), mild (215-250 dB), and severe (>300 dB) | A greater number of participants that were overweight, obese, and with a higher waist circumference fell into the Severe NAFLD category |
| Franco et al., 2020 [ | Observational study: randomized clinical trial | 144 moderate or severe NAFLD patients | Participants were assigned six interventions arms during three months, which included control diet, low glycemic index Mediterranean diet, aerobic activity program, combined activity program, low glycemic index Mediterranean diet plus aerobic activity program, or low glycemic index Mediterranean diet plus combined activity program | NAFLD score significantly reduced after 45 days of treatment in every working arm except for the control diet group |
| Yaskolka et al., 2020 [ | Observational study: randomized clinical trial | 294 participants with abdominal obesity/dyslipidemia | Participants assigned into one of the three groups: healthy dietary guidelines, Mediterranean diet, or green-Mediterranean weight-loss diet, all accompanied by physical activity | NAFLD prevalence declined with the Mediterranean diet, and after 18 months, both Mediterranean groups had significantly higher total plasma polyphenols. Also, intra-hepatic fraction percentage loss was seen with Mankai and walnuts intake and decreased red/processed meat consumption |
| Campanella et al., 2020 [ | Observational study: randomized clinical trial | 556 participants | Participants were assigned to one of three diets (Mediterranean diet, low glycemic Mediterranean diet, low glycemic index Mediterranean diet) or the control group. Anthropometric variables were noted for each participant, and the outcome of NAFLD was observed | Low glycemic index Mediterranean diet is more effective than other diets in reducing elevated fasting remnant cholesterol |
| Baratta et al., 2020 [ | Cohort study | 238 participants | Liver ultrasound and Mediterranean-diet questionnaire was done, along with serum sNox2-dp activity, and serum lipopolysaccharide levels measured for each participant | Out of 238 participants, 193 (81.1%) had liver steatosis, with results suggesting that the Med-Diet improves redox status and can be a beneficial approach in NAFLD |
Literature reviews illustrating the relationship between NAFLD and the Mediterranean diet
EASL: European Association for the Study of the Liver; EASD: European Association for the Study of Diabetes; EASO: European Association for the Study of Obesity; NAFLD: non-alcoholic fatty liver disease
| References | Study type | Purpose of study | Relevant results/conclusions |
| Hsu et al., 2017 [ | Traditional review | Analysis of current treatment and dietary approaches for NAFLD | NAFLD patients should follow a low-sodium and low-low-fructose diet, as the Mediterranean diet has shown to be effective in improving hepatic steatosis |
| Abenavoli et al., 2017 [ | Traditional review | Re-evaluate the treatment options for NAFLD and primarily focus on the Mediterranean diet as a potential upcoming first-line treatment option. | Adherence to the traditional Mediterranean diet, rich in antioxidants and polyphenols, is a potential new approach in the treatment and prevention of NAFLD |
| George et al., 2018 [ | Traditional review | Review the current evidence for the effects of dietary intake in adults with NAFLD and translate these dietary recommendations to guidelines for clinical practice | Implement of the different components of the Mediterranean diet are likely to reduce the onset and progression of NAFLD |
| Akhlaghi et al., 2020 [ | Systematic review and meta-analysis | Review the literature on the benefits of the Mediterranean diet for NAFLD | Adherence to the Mediterranean diet is associated with a reduced risk of overall mortality |
| Abenavoli et al., 2019 [ | Traditional review | Evaluate the effects of the Mediterranean diet’s anti-oxidant intake on NAFLD. | The Mediterranean diet is suggested in patients with NAFLD patients as an appropriate approach to prevent its onset and development of further disease complications |
| Plaz Torres et al., 2019 [ | Traditional review | Overlooks the benefits of the Mediterranean diet in NAFLD patients and analysis the liver outcome | EASL/EASD/EASO NAFLD guidelines recommend diet and physical activity as the best treatment for steatosis |
| Mirabelli et al., 2020 [ | Traditional review | Review current evidence about the role of MedDiet and its effects on insulin resistance-related diseases | The MedDiet provides protection from insulin resistance-related diseases such as obesity, type 2 diabetes mellitus, and NAFLD |
| Margină et al., 2020 [ | Traditional review | Review the different cellular pathways that are affected by our everyday dietary habits and look into the next steps in addressing these parameters | Diet plays a major role in regulating many cellular pathways, with certain foods components influencing the development of certain diseases |